ContractJuly 9th, 2020
FiledJuly 9th, 2020AMENDMENT # 2 TO CLINICAL TRIAL AGREEMENT DODATEK Č. 2 KE SMLOUVĚ O PROVEDENÍ KLINICKÉHO HODNOCENÍ Protocol REX-001-004 Protokol REX-001-004 This Amendment # 2 (“Amendment”), dated as of date of last signature and effective as of date of publishing of this Amendment in the Agreement Registry (“Effective Date”) between Tento dodatek č. 2 (“dodatek”) ze dne připojení posledního podpisu a účinný dnem uveřejnění tohoto dodatku v registru smluv (“datum účinnosti”) mezi Syneos Health UK Limited with principal offices located in the United Kingdom at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, United Kingdom (formerly named INC Research UK Limited and formerly located at Riverview, the Meadows Business Park, Station Approach, Blackwater, Camberley, Surrey GU17 9AB, United Kingdom) (hereinafter “CRO”) Syneos Health UK Limited se sídlem ve Spojeném království ve Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, Spojené království (